Prevalence and risk factors for malignancy in hysteroscopy-resected endometrial polyps

Int J Gynaecol Obstet. 2021 Dec;155(3):433-441. doi: 10.1002/ijgo.13656. Epub 2021 Mar 20.

Abstract

Introduction: To determine the prevalence of malignant lesions in endometrial polyps by hysteroscopic polypectomy, and risk factors for malignant transformation. The secondary aim was to evaluate background endometrium of atypical hyperplasia in endometrial polyps, and the risk of coexisting endometrial carcinoma after hysterectomy.

Methods: This retrospective study included women who underwent hysteroscopic polypectomy between January 2015 and December 2019. Demographic characteristics, hysteroscopic findings, and histopathology results of the polyp and the uterus, in the case of a hysterectomy, were collected.

Results: In all, 946 women were included in the study. Endometrial carcinoma in a polyp was found in 10 women (1.06%), and atypical hyperplasia was found in 11 women (1.16%). At the multivariate logistic regression model of risk factors, old age (P = 0.022) and obesity (P = 0.011) were significantly associated with (pre-)malignant polyp. Five of the ten women (50%) with atypical hyperplasia confined to a polyp had coexisting endometrial carcinoma in the hysterectomy specimen.

Conclusion: Women with risk factors should be offered hysteroscopic polypectomy to allow a reliable histologic evaluation. Furthermore, hysterectomy is recommended in women with atypical hyperplasia in endometrial polyps even after complete resection.

Keywords: atypical hyperplasia; hysteroscopy; malignancy; uterine polyps.

MeSH terms

  • Endometrial Neoplasms* / epidemiology
  • Endometrial Neoplasms* / pathology
  • Endometrial Neoplasms* / surgery
  • Endometrium / pathology
  • Female
  • Humans
  • Hysteroscopy
  • Polyps* / epidemiology
  • Polyps* / etiology
  • Polyps* / surgery
  • Pregnancy
  • Prevalence
  • Retrospective Studies
  • Risk Factors
  • Uterine Neoplasms* / pathology